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Introduction
The currently used SMAC glucose oxidase method is a
modification of the procedure of Gochman and Schmitz ].
In this colorimetirc determination, the specificity of glucose
oxidase is combined with a peroxidase indicator coupler,
3-methyl-2 benzothiazolinone hydrazone (MBTH) and
dimethylaniline (DMA) to form a coloured indamine dye
with a high molar absorption. However, as much as six
different reagents have to be prepared by the user, some of
them daily. Barham and Trinder [2] described in 1972 a
method involving the use of 4-aminophenazone as a colour
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Figure 1. Simplified flow diagram for the glucose channel
(DCPS/AP system).
coupler with sulphonated 2,4-dichlorophenol for determining
the hydrogen peroxide produced from glucose with glucose
oxidase. This method had a high sensitivity and the additional
possibility of using a single reagent stable for several days.
This paper presents an adaptation of the former to the SMAC
system considerably reducing both the number of reagents
involved and the operator-time consumed. The proposed
method was compared with the hexokinase manual method
and the Gochman-Schmitz method for the SMAC.
Materials and methods
Reagents
Reagents for SMAC glucose determination (MBTH/DMA)
Reagents were prepared according to the manufacturer [3].
Glucose oxidase working reagent: 1.6 ml of glucose oxidase
stock reagent (1000 U/l) were diluted with 163 ml of phos-
phate buffer 0.1 mol/1, pH 7.0 and 0.16 ml of 300 g/I
Brij-35.
MBTH/DMA working reagent: 2.0 ml of g/1 MBTH and
3.0 ml of 10 ml/1 DMA were diluted with 95.0 ml
of 0.5 mol/1 acetic acid. DMA and MBTH solutions were
prepared in 0.1 mol/1 hydrochloric acid.
Peroxidase: 19 U/ml in distilled water.
Glucose sample diluent: 9 g/1 saline-0.3 g/1 Brij-35.
Reagents proposed for SMAC glucose determination
(DCPS/AP)
Enzyme/chromogen mixture: The reagent contains, per
litre: 0.8 mmol aminophenazone, 10 mmol sulphonated
O.O.
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Figure 2. Representative recording of glucose determinations. Number above the peaks indicate the concentration of
glucose (mg/1 O0 ml).
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2,4-dichlorophenol, 10000 U glucose oxidase and 1100
U peroxidase in phosphate buffer 0.1 mol/1, pH 7.4. It can be
prepared in a stable powdered or lyophilised form suitable
for up to four days use when appropriately dissolved in water.
Glucose sample diluent: 0.3 g/1 Brij-3 5.
Instrumentation
The instrument used was a SMAC (Technicon Instruments
Corp, Tarrytown, NY, 10591). The flow diagram for the
DCPS/AP proposed method is shown in Figure 1. Modifi-
cations of the original channel are minimal: substitution of
the interference filter (500 nm for 600 nm) and disconnection
of the MBTH/DMA and peroxidase tubing.
Results and discussion
Linearity
Readings and glucose concentrations were linearly related
up to 27.5 mmol/1. A recording of the procedure for con-
tinuous sampling of standard sera, an ascending standard
curve and results with representative sera are reproduced in
Figure 2.
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Figure 3. Correlation analysis ofserum glucose determined
by the DCPS/AP system and the MBTH/DMA system
and by the DCPS/AP sysem and the manual hexokinase
procedure [B).
Table I. Day-to-day precision of automated glucose method
(I0 daily analysis).
Mean (mmol/l)
SD
CV(%)
n
’MBTH/DMA"
system
Serum A
DcPs/AP
system
4.17
0.15
3.60
25
4.21
0.12
2.85
25
Serum B
MBTH]DMA DcPs/AP
system system
13.37 13.57
0.33 0.28
2.47 2.06
25 25
Table 2. Interferences study. Solutions of the examined
compounds were added to a serum pool and the glucose
concentration was tested and compared with the same
pool diluted with saline. Glucose found is the mean of
triplicate results.
Added
Substance
Saline
Heparine
Citrate
EDTA
NaF
Oxalate
Glutathione
Ascorbic acid
Uric acid
Bilirubin
Cysteine
Fructose
Mannose
Xylose
Maltose
Galactose
Saccharose
Dextran
Creatinine
Salicylic acid
Acetylsalicylic
acid
Gentisic acid
L-DOPA
Haemoglobin
Haemolysate
Concentration
tested (mg/ml)
150,000 U/I
Normal
concentration
(mg/ml)*
Glucose
found (mmol/1)
6.39
6.39
200
60
300
3O
3O
7
5
1
2
7.5
30
30
3O
3O
3O
3O
30
2
2
10
0.2
0.1
5O
5O
3.1
3.1
0.3
0.3
0.5
0.1
0.001
0.1
0.04
0.03 -0.003
6.33
6.50
6.39
6.44
5.83
6.44
6.33
4.67
6.39
6.44
6.33
6.39
6.39
6.33
23.33
6..39
6.44
6.36
6.39
6.39
6.33
6.39
6.39
6.44
4.72
*Approximate normal values of the compound in serum
(physiological or therapeutical).
Precision
The precision of the method was determined by daffy analysis
of 2 lyophilised control sera with low and high glucose values.
The results are shown in Table 1. Data shows satisfactory
precision for consecutive runs involving change of reagents,
standards, etc.
Interferences
Various anticoagulants, drugs and metabolites were tested
for potential interferences with the method (Table 2). A
number of saccharides did not interfere reflecting the
specificity of the method, maltose being an exception. The
interference from maltose was due to the common
contamination of glucose oxidase with maltase. None of the
anticoagulants tested interfered. Glutathione, uric acid,
ascorbic acid and bilirubin did not interfere at concentrations
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Table 3. Recovery of glucose added to dialysed serum.
Found glucose is average of triplicate determinations.
Added glucose
(mmol/1)
2.78
5.56
13.89
22.22
Found
glucose (mmol/1)
2.83
5.50
14.17
22.44
Recovery
(%)
102
99
102
101
higher than those found in serum. The serum drug con-
centrations studied here were higher than would be expected
after therapeutic doses and no interference was observed.
Haemoglobin did not interfere up to 50 mg/ml, but a haemo-
lysate with the same concentration of haemoglobin produced
a decrease in the observed glucose value.
Accuracy and comparison of methods
Accuracy of the method was investigated by recovery studies
and by comparison with the spectrophotometric hexokinase
method. To investigate recovery a pool of human serum was
prepared by dialysing it overnight against saline. Various
amounts of glucose solution (555 mmol/1) and water were
added to the dialysed serum and analysed. The results are
shown in Table 3.. Recovery was excellent at low and high
glucose concentration. We compared our results for this
method to those obtained by the Boehringer-Mannheim
hexokinase manual procedure and by the MBTH/DMA
SMAC method for 85 freshly collected patients’ sera. The
data were correlated (Figure 3) and showed excellent agree-
ment over a wide range of plasma glucose values.
In conclusion, the proposed system is simpler and more
economical than the MBTH/DMA method, performing
similarly in linearity, sensitivity, resistance to interfering
substances, accuracy and precision.
Recently obtained data have shown a similar performance
of the proposed method in the SMA II system modified in
the glucose channel as described for the SMAC (results not
shown).
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A telephone is all it takes
to keep your autoanalysis
equipment in good shape.
One call to Sterilin Instru-
ments brings you everything
you could possibly need.
Quickly, and economically.
From emergency repairs to
preventative maintenance.
And from custom built
manifolds to a vast range of
accessories such as tubing,
coils, stream dividers, dialyser
plates, reagent filters, and
many many more.
All made to meet or surpass
OEM specifications.
And all at prices that won’t
shatter your budget.
We’ve been busy looking
after continuous flow
analysers since 1972 and we
know them inside-out.
Which means we can
completely refurbish your
existing equipment. Or
supply a new system.
Andwe also stock, a wide
range ofmodules and spare
parts.
Make a start by asking for
our catalogue-we’re just at the
other end ofyour telephone.
Sterilin
Instruments_/’
You’re safe with Sterilin
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